Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease.
Saved in:
| Title: | Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease. |
|---|---|
| Authors: | Wu VC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Lin YF; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Teng NC; Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan., Yang SY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chou NK; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan., Tsao CH; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan., Chen YM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Chueh JS; Glickman Urological and Kidney Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, United States.; Department of Urology, National Taiwan University Hospital, Taipei, Taiwan., Chen L; Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 Apr 20; Vol. 13, pp. 714658. Date of Electronic Publication: 2022 Apr 20 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
